New Formulation for PROTONIX

Wyeth Pharmaceuticals, a division of Wyeth, announced on April 12, 2004 that the U.S. Food and Drug Administration (FDA) approved the reformulation of the stomach acid suppressant, PROTONIX® I.V. (pantoprazole sodium) for Injection. Read more.